Sequent Scientific Ltd: Q1FY18 Results
DSIJ Intelligence / 03 Aug 2017
Sequent Scientific Ltd reported its consolidated result for Q1FY18. Its consolidated revenue for the quarter came in at Rs. 260.54 crore, registering 2.41% QoQ growth for the first quarter of FY2017-18.
Sequent Scientific Ltd reported its consolidated result for Q1FY18.
Its consolidated revenue for the quarter came in at Rs. 260.54 crore, registering 2.41% QoQ growth for the first quarter of FY2017-18.
For the quarter ended 30th June 2017, EBITDA contracted by 11.26% to Rs. 46.57 crore QoQ from Rs. 52 crore as on 31st March 2017. There was a contraction in EBITDA margin of 270 bps from 20.6% to 17.9% QoQ. Margins suffered due to 30% QoQ increase in employee benefit expense from Rs. 7.81 crore to Rs. 10.21 crore for the quarter end.
The company's net profit for the quarter weakened by 47.5% QoQ to Rs. 8.77 crore.
Sequent Scientific Ltd is a pharmaceutical company. Its business includes pharmaceuticals, specialty chemicals and analytical segments with focus on poultry, livestock and companion animals. It also operates across API therapeutic segments.
The stock opened at Rs 128.9 and closed at Rs. 122.5 after touching an intra-day high of Rs. 132.4.
If you want to stay updated with the share market news today, keep a close watch on the indian stock market today with real time movements like sensex today live and overall stock market today trends. Investors tracking ipo allotment status, ipo news today, or the latest ipo india can also follow daily updates along with bse share price live data. Whether you are learning how to invest in stock market in india, preparing for a market crash today, or searching for the best stocks to buy in india, insights on top gainers today india, top losers today india, trending stocks india and long term stocks india help in making informed investment decisions.